FY2024 Earnings Estimate for Option Care Health, Inc. (NASDAQ:OPCH) Issued By William Blair

Option Care Health, Inc. (NASDAQ:OPCH) – Analysts at William Blair increased their FY2024 earnings per share (EPS) estimates for Option Care Health in a report released on Wednesday, April 24th. William Blair analyst M. Larew now forecasts that the company will earn $1.19 per share for the year, up from their prior forecast of $1.17. The consensus estimate for Option Care Health’s current full-year earnings is $1.17 per share. William Blair also issued estimates for Option Care Health’s Q1 2025 earnings at $0.30 EPS, Q2 2025 earnings at $0.35 EPS, Q4 2025 earnings at $0.41 EPS and FY2025 earnings at $1.43 EPS.

Option Care Health (NASDAQ:OPCH) last announced its earnings results on Tuesday, April 23rd. The company reported $0.26 earnings per share for the quarter, beating the consensus estimate of $0.22 by $0.04. The firm had revenue of $1.15 billion during the quarter, compared to the consensus estimate of $1.10 billion. Option Care Health had a net margin of 6.15% and a return on equity of 18.92%. The firm’s revenue for the quarter was up 12.8% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.21 EPS.

OPCH has been the topic of a number of other reports. Barrington Research restated an “outperform” rating and issued a $38.00 price objective on shares of Option Care Health in a report on Wednesday. Jefferies Financial Group lifted their price target on shares of Option Care Health from $36.00 to $38.00 and gave the stock a “buy” rating in a research note on Monday, March 4th.

Option Care Health Stock Performance

NASDAQ:OPCH opened at $29.61 on Thursday. The company has a quick ratio of 1.33, a current ratio of 1.77 and a debt-to-equity ratio of 0.74. The company has a market cap of $5.15 billion, a P/E ratio of 19.48, a P/E/G ratio of 1.65 and a beta of 1.22. The firm’s 50 day moving average is $31.96 and its two-hundred day moving average is $31.48. Option Care Health has a fifty-two week low of $24.23 and a fifty-two week high of $35.74.

Insider Activity

In related news, Director Harry M. Jansen Kraemer, Jr. bought 35,000 shares of the firm’s stock in a transaction that occurred on Monday, February 26th. The stock was purchased at an average price of $31.55 per share, for a total transaction of $1,104,250.00. Following the transaction, the director now directly owns 269,528 shares of the company’s stock, valued at approximately $8,503,608.40. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 0.64% of the company’s stock.

Institutional Investors Weigh In On Option Care Health

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in OPCH. Principal Securities Inc. bought a new stake in shares of Option Care Health during the 4th quarter worth $27,000. Parallel Advisors LLC raised its stake in shares of Option Care Health by 130.2% in the 4th quarter. Parallel Advisors LLC now owns 845 shares of the company’s stock valued at $28,000 after buying an additional 478 shares in the last quarter. TFO Wealth Partners LLC raised its stake in Option Care Health by 24,625.0% during the fourth quarter. TFO Wealth Partners LLC now owns 989 shares of the company’s stock worth $33,000 after acquiring an additional 985 shares in the last quarter. First Horizon Advisors Inc. bought a new stake in Option Care Health during the third quarter worth about $37,000. Finally, Park Place Capital Corp boosted its stake in Option Care Health by 48.4% in the first quarter. Park Place Capital Corp now owns 1,140 shares of the company’s stock worth $38,000 after purchasing an additional 372 shares in the last quarter. Hedge funds and other institutional investors own 98.05% of the company’s stock.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.